Standard Biotools (LAB) Restructuring Costs (2013 - 2026)

Standard Biotools (LAB) has reported Restructuring Costs for 7 consecutive years, with $14.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Restructuring Costs rose 753.91% year-over-year to $14.7 million in Q2 2026; TTM through Jun 2026 was $29.3 million, a 159.26% increase from a year earlier, with the FY2025 full-year figure at $14.8 million, down 47.17% from the prior year.
• Restructuring Costs was $14.7 million for Q2 2026 at Standard Biotools, up from $3.1 million in the prior quarter.
• Over five years, Restructuring Costs peaked at $17.2 million in Q1 2024 and troughed at $300000.0 in Q2 2022.
• A 5-year average of $4.7 million and a median of $3.0 million in 2024 frame the typical range for Restructuring Costs.
• Across the five-year window, Restructuring Costs jumped 1330.25% in 2024 and slumped 90.96% in 2025, its largest moves.
• Over 5 years, Restructuring Costs stood at $4.6 million in 2022, then slumped by 63.61% to $1.7 million in 2023, then surged by 75.37% to $3.0 million in 2024, then declined by 29.78% to $2.1 million in 2025, then soared by 610.7% to $14.7 million in 2026.
• The last three Restructuring Costs figures came in at $14.7 million (Q2 2026), $3.1 million (Q1 2026), and $2.1 million (Q4 2025), per Business Quant data.